Nabiximols (THC/CBD Oromucosal Spray, Sativex®) in Clinical Practice - Results of a Multicenter, Non-Interventional Study (MOVE 2) in Patients with Multiple Sclerosis Spasticity
Year: 2014
Type: article
Study design: Observational Study
Source: European Neurology
DOI: 10.1159/000357427
Authors: Peter Flachenecker, Thomas Henze, Uwe K. Zettl
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funders: Biogen, IC Design Education Center
OpenAlex ID: W2067343268
